COMPARISON BETWEEN MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION (MLPA) AND CYTOGENETICS FOR VALIDATION OF CHROMOSOMAL ABERRATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Objective: Recently, a multiplex ligation-dependent probe amplification (MLPA®) has emerged as a method that is reported to be fast, sensitive, and cost-effective that can detect copy number variation. In the present study, MLPA analysis was compared with chromosome banding analysis (CBA) data to de...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-10-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137921008737 |
| _version_ | 1818585191284736000 |
|---|---|
| author | L Nardinelli RR Giorgi ARL Ruiz AM Leal PBF Pinotti AMC Ferreira EDRP Velloso V Buccheri V Rocha I Bendit |
| author_facet | L Nardinelli RR Giorgi ARL Ruiz AM Leal PBF Pinotti AMC Ferreira EDRP Velloso V Buccheri V Rocha I Bendit |
| author_sort | L Nardinelli |
| collection | DOAJ |
| description | Objective: Recently, a multiplex ligation-dependent probe amplification (MLPA®) has emerged as a method that is reported to be fast, sensitive, and cost-effective that can detect copy number variation. In the present study, MLPA analysis was compared with chromosome banding analysis (CBA) data to determine the efficiency of MLPA in patients with chronic lymphocytic leukemia (CLL). Materials and methods: CBA karyotyped 65 patients. Chromosomal analysis was performed on G-banded metaphase cells from cultured lymphocytes in a culture medium at 37°C for 72 hours. Numerical, as well as structural abnormalities were reported on at least 20 well-spread and well-banded metaphases. Genomic DNA was extracted from peripheral blood samples and subjected to MLPA through the probemix, kit SALSA®MLPA®P037 containing 54 MLPA probes, including 41 probes for 2p, 6q 8p/q, 9p21, 11q, 12p/q, 13q, and 17p chromosomal regions. The PCR products were separated by capillary electrophoresis using an ABI 3500 DNA analyzer. Results: Cytogenetics resulted in 41 normal karyotypes, and 25 karyotype aberrations (13 tris12; 3 del13; 2 del11; 4 del17; others 3). Genetic abnormalities observed by MLPA were 45 (14 tris12; 26 del13q; 2 del11q; 3 TP53 deletion), and 22 were normal by MLPA. Of the 41 normal cytogenetics, MLPA was concordant in 20 patients and discordant in 21 patients. Of those 21, MLPA identified 19 del13q, 1 delq11, and 1 tris12. Regarding abnormalities, cytogenetics and MLPA were concordant in 12 tris12, 2 del13, 3 del17, and 1 del11. Statistical difference was seen when comparing both methodologies in favor of MLPA (p= 0.003; chi-square test). Discussion and conclusion: In this study, we aimed to determine the usefulness of the MLPA probemix P037-B1 as a routine for detecting clinically relevant chromosome abnormalities in CLL in laboratories without cytogenetic routine. MLPA identified more abnormalities than cytogenetic (44%). We observed that MLPA was consistent with the cytogenetic results in 20 of 41 normal patients (48%). The main discordant results identified by MLPA were 13q deletion, the most common cytogenetic change in chronic lymphoblastic leukemia (CLL). In one patient, results of the MLPA did not show deletion in the TP53 gene, while isochromosome 17 was observed by cytogenetic. A low proportion of malignant cells with the relevant abnormality could be responsible for the discrepancies in the MLPA technique. Besides that pitfall, our findings highlight the advantage of MLPA compared with conventional cytogenetics. In conclusion, MLPA is a reliable high-throughput technique to detect CNVs and a cost-effective one that can be included in routine diagnostic protocols in laboratories that lack conventional cytogenetics. |
| first_indexed | 2024-12-16T08:33:09Z |
| format | Article |
| id | doaj.art-6a517408c48c49e6bf4427b1cc7a82c9 |
| institution | Directory Open Access Journal |
| issn | 2531-1379 |
| language | English |
| last_indexed | 2024-12-16T08:33:09Z |
| publishDate | 2021-10-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Hematology, Transfusion and Cell Therapy |
| spelling | doaj.art-6a517408c48c49e6bf4427b1cc7a82c92022-12-21T22:37:49ZengElsevierHematology, Transfusion and Cell Therapy2531-13792021-10-0143S423S424COMPARISON BETWEEN MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION (MLPA) AND CYTOGENETICS FOR VALIDATION OF CHROMOSOMAL ABERRATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIAL Nardinelli0RR Giorgi1ARL Ruiz2AM Leal3PBF Pinotti4AMC Ferreira5EDRP Velloso6V Buccheri7V Rocha8I Bendit9Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), São Paulo, SP, Brazil; Laboratório de Biologia Tumoral da Disciplina de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, BrazilLaboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), São Paulo, SP, BrazilLaboratório de Biologia Tumoral da Disciplina de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, BrazilLaboratório de Citogenética da Disciplina de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, BrazilLaboratório de Citogenética da Disciplina de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, BrazilLaboratório de Biologia Tumoral da Disciplina de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, BrazilLaboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), São Paulo, SP, Brazil; Instituto do Câncer do Estado de São Paulo (ICESP), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, BrazilLaboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), São Paulo, SP, Brazil; Instituto do Câncer do Estado de São Paulo (ICESP), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, BrazilLaboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), São Paulo, SP, Brazil; Instituto do Câncer do Estado de São Paulo (ICESP), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, BrazilLaboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), São Paulo, SP, Brazil; Laboratório de Biologia Tumoral da Disciplina de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, BrazilObjective: Recently, a multiplex ligation-dependent probe amplification (MLPA®) has emerged as a method that is reported to be fast, sensitive, and cost-effective that can detect copy number variation. In the present study, MLPA analysis was compared with chromosome banding analysis (CBA) data to determine the efficiency of MLPA in patients with chronic lymphocytic leukemia (CLL). Materials and methods: CBA karyotyped 65 patients. Chromosomal analysis was performed on G-banded metaphase cells from cultured lymphocytes in a culture medium at 37°C for 72 hours. Numerical, as well as structural abnormalities were reported on at least 20 well-spread and well-banded metaphases. Genomic DNA was extracted from peripheral blood samples and subjected to MLPA through the probemix, kit SALSA®MLPA®P037 containing 54 MLPA probes, including 41 probes for 2p, 6q 8p/q, 9p21, 11q, 12p/q, 13q, and 17p chromosomal regions. The PCR products were separated by capillary electrophoresis using an ABI 3500 DNA analyzer. Results: Cytogenetics resulted in 41 normal karyotypes, and 25 karyotype aberrations (13 tris12; 3 del13; 2 del11; 4 del17; others 3). Genetic abnormalities observed by MLPA were 45 (14 tris12; 26 del13q; 2 del11q; 3 TP53 deletion), and 22 were normal by MLPA. Of the 41 normal cytogenetics, MLPA was concordant in 20 patients and discordant in 21 patients. Of those 21, MLPA identified 19 del13q, 1 delq11, and 1 tris12. Regarding abnormalities, cytogenetics and MLPA were concordant in 12 tris12, 2 del13, 3 del17, and 1 del11. Statistical difference was seen when comparing both methodologies in favor of MLPA (p= 0.003; chi-square test). Discussion and conclusion: In this study, we aimed to determine the usefulness of the MLPA probemix P037-B1 as a routine for detecting clinically relevant chromosome abnormalities in CLL in laboratories without cytogenetic routine. MLPA identified more abnormalities than cytogenetic (44%). We observed that MLPA was consistent with the cytogenetic results in 20 of 41 normal patients (48%). The main discordant results identified by MLPA were 13q deletion, the most common cytogenetic change in chronic lymphoblastic leukemia (CLL). In one patient, results of the MLPA did not show deletion in the TP53 gene, while isochromosome 17 was observed by cytogenetic. A low proportion of malignant cells with the relevant abnormality could be responsible for the discrepancies in the MLPA technique. Besides that pitfall, our findings highlight the advantage of MLPA compared with conventional cytogenetics. In conclusion, MLPA is a reliable high-throughput technique to detect CNVs and a cost-effective one that can be included in routine diagnostic protocols in laboratories that lack conventional cytogenetics.http://www.sciencedirect.com/science/article/pii/S2531137921008737 |
| spellingShingle | L Nardinelli RR Giorgi ARL Ruiz AM Leal PBF Pinotti AMC Ferreira EDRP Velloso V Buccheri V Rocha I Bendit COMPARISON BETWEEN MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION (MLPA) AND CYTOGENETICS FOR VALIDATION OF CHROMOSOMAL ABERRATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA Hematology, Transfusion and Cell Therapy |
| title | COMPARISON BETWEEN MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION (MLPA) AND CYTOGENETICS FOR VALIDATION OF CHROMOSOMAL ABERRATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_full | COMPARISON BETWEEN MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION (MLPA) AND CYTOGENETICS FOR VALIDATION OF CHROMOSOMAL ABERRATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_fullStr | COMPARISON BETWEEN MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION (MLPA) AND CYTOGENETICS FOR VALIDATION OF CHROMOSOMAL ABERRATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_full_unstemmed | COMPARISON BETWEEN MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION (MLPA) AND CYTOGENETICS FOR VALIDATION OF CHROMOSOMAL ABERRATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_short | COMPARISON BETWEEN MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION (MLPA) AND CYTOGENETICS FOR VALIDATION OF CHROMOSOMAL ABERRATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_sort | comparison between multiplex ligation dependent probe amplification mlpa and cytogenetics for validation of chromosomal aberrations in chronic lymphocytic leukemia |
| url | http://www.sciencedirect.com/science/article/pii/S2531137921008737 |
| work_keys_str_mv | AT lnardinelli comparisonbetweenmultiplexligationdependentprobeamplificationmlpaandcytogeneticsforvalidationofchromosomalaberrationsinchroniclymphocyticleukemia AT rrgiorgi comparisonbetweenmultiplexligationdependentprobeamplificationmlpaandcytogeneticsforvalidationofchromosomalaberrationsinchroniclymphocyticleukemia AT arlruiz comparisonbetweenmultiplexligationdependentprobeamplificationmlpaandcytogeneticsforvalidationofchromosomalaberrationsinchroniclymphocyticleukemia AT amleal comparisonbetweenmultiplexligationdependentprobeamplificationmlpaandcytogeneticsforvalidationofchromosomalaberrationsinchroniclymphocyticleukemia AT pbfpinotti comparisonbetweenmultiplexligationdependentprobeamplificationmlpaandcytogeneticsforvalidationofchromosomalaberrationsinchroniclymphocyticleukemia AT amcferreira comparisonbetweenmultiplexligationdependentprobeamplificationmlpaandcytogeneticsforvalidationofchromosomalaberrationsinchroniclymphocyticleukemia AT edrpvelloso comparisonbetweenmultiplexligationdependentprobeamplificationmlpaandcytogeneticsforvalidationofchromosomalaberrationsinchroniclymphocyticleukemia AT vbuccheri comparisonbetweenmultiplexligationdependentprobeamplificationmlpaandcytogeneticsforvalidationofchromosomalaberrationsinchroniclymphocyticleukemia AT vrocha comparisonbetweenmultiplexligationdependentprobeamplificationmlpaandcytogeneticsforvalidationofchromosomalaberrationsinchroniclymphocyticleukemia AT ibendit comparisonbetweenmultiplexligationdependentprobeamplificationmlpaandcytogeneticsforvalidationofchromosomalaberrationsinchroniclymphocyticleukemia |